Detalhe da pesquisa
1.
CAR/CXCR5-T cell immunotherapy is safe and potentially efficacious in promoting sustained remission of SIV infection.
PLoS Pathog
; 18(2): e1009831, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35130312